Adverse drug reactions profile of new drugs for Hepatits C (2016)
- Authors:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Subjects: HEPATITE C; MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 52, suppl. 1, p. 27 res. FCF050, 2016
- Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
KOHATSU, Denise Yukari e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 mar. 2026. , 2016 -
APA
Kohatsu, D. Y., Ribeiro, A. G., & Kano, E. K. (2016). Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2026 mar. 16 ] -
Vancouver
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2026 mar. 16 ] - Desenvolvimento e validação de método bioanalítico para quantificação de fluconazol em plasma humano
- Development and validation of a bioanalytical method for quantification of fluconazole in human plasma
- Cloxacillin benzathine-loaded polymeric nanocapsules: physicochemical characterization, cell uptake, and intramammary antimicrobial effect
- Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs)
- Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment
- Atrioventricular block associated with the first dose of fingolimod
- Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis
- Insulin Glargine and cancer incidence
- Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis
- Risk of pancreatic cancer associated with therapy based on incretins
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
